BioSpace News Archive

Business

Medable Hires Sanskriti Thakur as Chief Growth Officer to Lead Market Expansion

Medable Inc. , the leading cloud platform for patient-centered drug development, today announced the hiring of Sanskriti Thakur as chief growth officer.

June 17, 2021
·
3 min read
Lone Star Bio

KRBP Presenting at July 2021 Gamma Delta T Cell Summit to Showcase Our Off-The-Shelf Allogeneic Gamma Delta T Cell Therapy

Kiromic is being recognized as a pioneer of Gamma Delta T (GDT) cell therapy manufacturing and has been invited to present its off-the-shelf allogeneic CAR-T technology at the prestigious Gamma Delta T Cell Summit in July 2021.

June 17, 2021
·
4 min read
Genetown

Mustang Bio Awarded Massachusetts Life Sciences Center Tax Incentive

Mustang Bio, Inc. announced that it was one of 28 recipients awarded tax incentives from the Massachusetts Life Sciences Center.

June 17, 2021
·
3 min read
Drug Development

Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Biology Conference: Fundamental Mechanisms and Translational Applications

Surrozen Inc. announced today that data from preclinical studies were presented in four oral Abstract Flash Talk presentations during The Liver Biology Conference.

June 17, 2021
·
10 min read
Genetown

Entera Bio Receives Foundational Patent for its Oral PTH using its Platform Oral Protein Delivery Technology in European Union

Entera Bio Ltd. today announced the European Patent Office has granted a patent titled “Methods and Compositions for Oral Administration of Proteins”

June 17, 2021
·
7 min read
Genetown

Vor to Build-Out State-of-the-Art Clinical Manufacturing Facility Capable of Supporting Multiple Cell Therapy Programs

Vor Biopharma announced that it will build-out an in-house clinical manufacturing facility in Cambridge, Massachusetts to support its development of potentially transformative engineered hematopoietic stem cell and chimeric antigen receptor T-cell therapeutic candidates for patients with hematological malignancies.

June 17, 2021
·
4 min read
KIYATEC Clinical Study Data Shows Test Accurately Predicts Brain Cancer Patient Response to Standard Drug Therapy Prior to Treatment

KIYATEC, Inc . announced today the publication of new peer-reviewed data that establishes clinically meaningful prediction of patient-specific responses to standard of care therapy, prior to treatment, in newly diagnosed glioblastoma (GBM).

June 17, 2021
·
4 min read
Genetown

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Apollo Therapeutics, a portfolio-based biopharmaceutical company rapidly advancing potentially transformative treatments based on breakthrough discoveries, has completed a $145 million financing.

June 17, 2021
·
7 min read
Wound Closure Devices Market: Increasing Number of Accidents and Mishaps Occurring Across the Globe to Drive the Market

Wound closure devices are the devices that aid in closing down a wound. It is done by pulling down the wound edges and tissues together and help in healing.

June 17, 2021
·
4 min read
Sequana Medical to Host a Key Opinion Leader Webinar on “The Impact of Liver Ascites on Patients and Healthcare Systems and the potential of alfapump® therapy in NASH-related ascites”

Sequana Medical NV, an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces that it will host a Key Opinion Leader call on July 15th, 2021 from 4 pm CET / 10 am ET to 5 pm CET / 11 am ET.

June 17, 2021
·
7 min read